NEW HAVEN, Conn., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) and the SPEAR Study Group today announced the plan to initiate a Phase 2 clinical trial evaluating monoclonal antibody ...

As Lindsey Vonn’s comeback run heads toward a peak with Team USA at the upcoming 2026 Winter Olympics, Invivyd is adding the ...

The prohibition halts support for projects both inside and outside the N.I.H. President Biden had restored funding after an ...

Elfenbein, a physician who trained at Johns Hopkins and contracted for the United States Secret Service (USSS), earned ...

If you feel like everyone you know is dealing with a cough, cold and runny nose, it’s not in your head. Multiple viruses, not ...

Amid a surprisingly severe flu season and a Covid-19 resurgence, those highly contagious respiratory illnesses are drawing ...

The global biosimilar monoclonal antibody market revenue was around US$ 10.6 billion in 2023 and is estimated to reach US$ 64.7 billion by 2032, growing at a compound annual growth rate (CAGR) of 22.2 ...

Amid a surprisingly severe flu season and a COVID-19 resurgence, those highly contagious respiratory illnesses are drawing ...

America has an Alzheimer’s problem, devastating families and driving soaring healthcare costs. More than 7 million people over 65 years old live with Alzheimer’s dementia today, a number predicted to ...

Researchers at the University of California, Davis, have uncovered new details about how a once-deadly coronavirus disease in ...

SHELTON, CONNECTICUT / ACCESS Newswire / January 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...